← All organizations

Vitreous -Retina- Macula Consultants of New York (VRMNY)

Academic/HospitalWebsite ↗

Also known as: Vitreous -Retina- Macula Consultants of New York | Vitreous Retina Macula Consultants of New York, P.C.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jul 31, 2018

Timeline

1970s

Jan 1, 1974
Vitreous -Retina- Macula Consultants of New York (VRMNY)— Founded

Drugs by trial phase (7 distinct, 10 trials)

Phase 4 (1 own, 0 via acquisition)

aflibercept

Phase 2 (1 own, 0 via acquisition)

ranibizumab

Phase 1 (3 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT03594461Overall official - principal investigatorPhase 1/Phase 2Jul 31, 2018
NCT03594461Lead sponsorPhase 1/Phase 2Jul 31, 2018
NCT01714115Lead sponsorN/AOct 16, 2012
NCT01495208Lead sponsorPhase 4Dec 1, 2011
NCT01495221Lead sponsorPhase 4Dec 1, 2011
NCT01495208Overall official - principal investigatorPhase 4Dec 1, 2011
NCT01115556Overall official - principal investigatorPhase 1/Phase 2May 1, 2010
NCT01115556Lead sponsorPhase 1/Phase 2May 1, 2010
NCT00726466Lead sponsorPhase 1Mar 1, 2008
NCT00726466Overall official - principal investigatorPhase 1Mar 1, 2008
NCT00457678Lead sponsorN/AApr 4, 2007
NCT00403156Lead sponsorPhase 1Nov 1, 2006
NCT00403156Overall official - principal investigatorPhase 1Nov 1, 2006
NCT00403039Lead sponsorPhase 1Nov 1, 2006
NCT00403039Overall official - principal investigatorPhase 1Nov 1, 2006

Details

Founded: New York, NY, US Jan 1, 1974
Last known activity: Jul 31, 2018